The hyperbaric oxygen therapy devices market size has grown strongly in recent years. It will grow from $4.58 billion in 2025 to $5.01 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to use of HBOT in decompression sickness treatment, growing hospital adoption for wound care, increasing awareness of oxygen-based therapies, expansion of trauma and emergency care services, clinical acceptance of adjunctive hyperbaric treatments.
The hyperbaric oxygen therapy devices market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising prevalence of chronic wounds and diabetic ulcers, growing demand for non-invasive therapeutic options, expansion of outpatient and home care services, increasing healthcare investment in advanced therapies, broader clinical indications for hyperbaric oxygen therapy. Major trends in the forecast period include expansion of hyperbaric therapy in chronic wound management, growing adoption of monoplace and portable HBOT devices, increasing use of HBOT in infection and post-surgical recovery, rising demand for home-based and outpatient HBOT solutions, standardization of safety and treatment protocols in hyperbaric centers.
The increasing prevalence of diabetes is poised to drive the expansion of the hyperbaric oxygen therapy device market in the coming years. Diabetes encompasses a group of chronic metabolic disorders characterized by elevated blood sugar levels over an extended period. Factors contributing to the rise in diabetes cases include sedentary lifestyles, poor dietary habits, obesity, genetic predispositions, aging populations, urbanization, and socioeconomic influences. Hyperbaric oxygen therapy devices present a supplementary approach to diabetes management by promoting wound healing and tissue repair through the administration of high-pressure oxygen. This therapy holds the potential to mitigate complications such as diabetic foot ulcers and enhance overall outcomes for individuals with diabetes. For instance, data from the Institute for Health Metrics and Evaluation (IHME) projects a surge in global diabetes cases from 529 million in 2023 to 1.3 billion by 2050, with the prevalence rate expected to rise substantially. The highest prevalence rate, currently at 9.3% in North Africa and the Middle East, is forecasted to reach 16.8% by 2050. Thus, the increasing prevalence of diabetes is a key driver of the hyperbaric oxygen therapy device market.
Major players in the hyperbaric oxygen therapy device market are integrating automated logging software into hyperbaric chambers to enhance treatment precision, efficiency, and patient care. This integration enables healthcare professionals to accurately monitor treatment parameters in real-time, ensuring meticulous documentation, streamlined reporting, and enhanced patient safety throughout therapy sessions. For instance, in January 2024, Sechrist Industries Inc., a US-based manufacturer of hyperbaric oxygen chambers and respiratory equipment, introduced the 3300 HM Hyperbaric Chamber and the eHEAL System. The 3300 HM Hyperbaric Chamber prioritizes patient comfort and safety with its modern design and innovative Patient Step-in Entry, eliminating the need for a hyperbaric stretcher. Enhanced safety features, user-friendly breathing systems, and versatile compression options cater to diverse medical needs. Meanwhile, the eHEAL System streamlines hyperbaric treatment logging with its intuitive interface, automated data capture, multi-chamber connectivity, and comprehensive logging capabilities, ensuring accuracy, efficiency, and security in treatment records, while seamlessly integrating with existing systems.
In July 2023, O2 Worx, a UK-based manufacturing and technology company, formed a partnership with Submarine Manufacturing and Products (SMP). The partnership aims to leverage the combined expertise of both companies to accelerate the growth and market expansion of O2 Worx’s hyperbaric oxygen therapy (HBOT) chambers. Submarine Manufacturing & Products Limited (SMP) is a UK-based company specializing in the design and manufacture of high-quality HBOT chambers and related equipment.
Major companies operating in the hyperbaric oxygen therapy devices market are Environmental Tectonics Corporation, Sechrist Industries, Perry Baromedical, HAUX Life Support, Fink Engineering, OxyHelp Industry, Environmental Control Systems, BioBarica, OxyHeal Health Group, Hyperbaric Modular Systems, Baroks Hyperbaric, Oxyvein Hyperbaric Chambers, Hpotech Medical Solutions, Shanghai Baobang Medical Equipment, Jiangsu Haila Resuscitation Equipment, Hyperbaric SAC, Pan America Hyperbarics Manufacturing, Oxymed Hyperbaric Chambers, Vitaeris Hyperbaric Systems, SOS Group Hyperbaric Engineering, ETC Hyperbaric Solutions, OxyAir Hyperbaric Technology.
North America was the largest region in the hyperbaric oxygen therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperbaric oxygen therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyperbaric oxygen therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hyperbaric oxygen therapy devices market by increasing costs for imported pressure vessels, valves, monitoring systems, and specialized medical-grade materials. These effects are most pronounced in north america and asia-pacific, where manufacturers rely on globally sourced components for monoplace and multiplace chambers. Higher equipment costs have influenced purchasing decisions by hospitals and specialty centers. However, tariffs are also encouraging localized manufacturing, regional supplier development, and cost-optimized chamber designs, supporting long-term supply chain resilience.
The hyperbaric oxygen therapy devices market research report is one of a series of new reports that provides hyperbaric oxygen therapy devices market statistics, including hyperbaric oxygen therapy devices industry global market size, regional shares, competitors with a hyperbaric oxygen therapy devices market share, detailed hyperbaric oxygen therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the hyperbaric oxygen therapy devices industry. This hyperbaric oxygen therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hyperbaric oxygen therapy (HBOT) devices are specialized medical equipment utilized for administering hyperbaric oxygen therapy, which involves breathing pure oxygen in a pressurized chamber. This enables the lungs to absorb more oxygen than would be possible at normal air pressure, facilitating the delivery of oxygen to the body's tissues and organs and promoting various therapeutic effects.
The primary types of hyperbaric oxygen therapy devices include monoplace hyperbaric oxygen therapy devices, multiplace hyperbaric oxygen therapy devices, and topical hyperbaric oxygen therapy devices. Monoplace hyperbaric oxygen therapy devices are chambers designed to accommodate a single patient during treatment sessions. They find applications in wound healing, decompression sickness, infection treatment, gas embolism, and other medical conditions and are utilized by hospitals, home care facilities, and other healthcare settings.
The hyperbaric oxygen therapy (HBOT) device market consists of sales of portable hyperbaric chambers, hyperbaric oxygen concentrators, and hyperbaric oxygen therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hyperbaric oxygen therapy devices market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising prevalence of chronic wounds and diabetic ulcers, growing demand for non-invasive therapeutic options, expansion of outpatient and home care services, increasing healthcare investment in advanced therapies, broader clinical indications for hyperbaric oxygen therapy. Major trends in the forecast period include expansion of hyperbaric therapy in chronic wound management, growing adoption of monoplace and portable HBOT devices, increasing use of HBOT in infection and post-surgical recovery, rising demand for home-based and outpatient HBOT solutions, standardization of safety and treatment protocols in hyperbaric centers.
The increasing prevalence of diabetes is poised to drive the expansion of the hyperbaric oxygen therapy device market in the coming years. Diabetes encompasses a group of chronic metabolic disorders characterized by elevated blood sugar levels over an extended period. Factors contributing to the rise in diabetes cases include sedentary lifestyles, poor dietary habits, obesity, genetic predispositions, aging populations, urbanization, and socioeconomic influences. Hyperbaric oxygen therapy devices present a supplementary approach to diabetes management by promoting wound healing and tissue repair through the administration of high-pressure oxygen. This therapy holds the potential to mitigate complications such as diabetic foot ulcers and enhance overall outcomes for individuals with diabetes. For instance, data from the Institute for Health Metrics and Evaluation (IHME) projects a surge in global diabetes cases from 529 million in 2023 to 1.3 billion by 2050, with the prevalence rate expected to rise substantially. The highest prevalence rate, currently at 9.3% in North Africa and the Middle East, is forecasted to reach 16.8% by 2050. Thus, the increasing prevalence of diabetes is a key driver of the hyperbaric oxygen therapy device market.
Major players in the hyperbaric oxygen therapy device market are integrating automated logging software into hyperbaric chambers to enhance treatment precision, efficiency, and patient care. This integration enables healthcare professionals to accurately monitor treatment parameters in real-time, ensuring meticulous documentation, streamlined reporting, and enhanced patient safety throughout therapy sessions. For instance, in January 2024, Sechrist Industries Inc., a US-based manufacturer of hyperbaric oxygen chambers and respiratory equipment, introduced the 3300 HM Hyperbaric Chamber and the eHEAL System. The 3300 HM Hyperbaric Chamber prioritizes patient comfort and safety with its modern design and innovative Patient Step-in Entry, eliminating the need for a hyperbaric stretcher. Enhanced safety features, user-friendly breathing systems, and versatile compression options cater to diverse medical needs. Meanwhile, the eHEAL System streamlines hyperbaric treatment logging with its intuitive interface, automated data capture, multi-chamber connectivity, and comprehensive logging capabilities, ensuring accuracy, efficiency, and security in treatment records, while seamlessly integrating with existing systems.
In July 2023, O2 Worx, a UK-based manufacturing and technology company, formed a partnership with Submarine Manufacturing and Products (SMP). The partnership aims to leverage the combined expertise of both companies to accelerate the growth and market expansion of O2 Worx’s hyperbaric oxygen therapy (HBOT) chambers. Submarine Manufacturing & Products Limited (SMP) is a UK-based company specializing in the design and manufacture of high-quality HBOT chambers and related equipment.
Major companies operating in the hyperbaric oxygen therapy devices market are Environmental Tectonics Corporation, Sechrist Industries, Perry Baromedical, HAUX Life Support, Fink Engineering, OxyHelp Industry, Environmental Control Systems, BioBarica, OxyHeal Health Group, Hyperbaric Modular Systems, Baroks Hyperbaric, Oxyvein Hyperbaric Chambers, Hpotech Medical Solutions, Shanghai Baobang Medical Equipment, Jiangsu Haila Resuscitation Equipment, Hyperbaric SAC, Pan America Hyperbarics Manufacturing, Oxymed Hyperbaric Chambers, Vitaeris Hyperbaric Systems, SOS Group Hyperbaric Engineering, ETC Hyperbaric Solutions, OxyAir Hyperbaric Technology.
North America was the largest region in the hyperbaric oxygen therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperbaric oxygen therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyperbaric oxygen therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hyperbaric oxygen therapy devices market by increasing costs for imported pressure vessels, valves, monitoring systems, and specialized medical-grade materials. These effects are most pronounced in north america and asia-pacific, where manufacturers rely on globally sourced components for monoplace and multiplace chambers. Higher equipment costs have influenced purchasing decisions by hospitals and specialty centers. However, tariffs are also encouraging localized manufacturing, regional supplier development, and cost-optimized chamber designs, supporting long-term supply chain resilience.
The hyperbaric oxygen therapy devices market research report is one of a series of new reports that provides hyperbaric oxygen therapy devices market statistics, including hyperbaric oxygen therapy devices industry global market size, regional shares, competitors with a hyperbaric oxygen therapy devices market share, detailed hyperbaric oxygen therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the hyperbaric oxygen therapy devices industry. This hyperbaric oxygen therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hyperbaric oxygen therapy (HBOT) devices are specialized medical equipment utilized for administering hyperbaric oxygen therapy, which involves breathing pure oxygen in a pressurized chamber. This enables the lungs to absorb more oxygen than would be possible at normal air pressure, facilitating the delivery of oxygen to the body's tissues and organs and promoting various therapeutic effects.
The primary types of hyperbaric oxygen therapy devices include monoplace hyperbaric oxygen therapy devices, multiplace hyperbaric oxygen therapy devices, and topical hyperbaric oxygen therapy devices. Monoplace hyperbaric oxygen therapy devices are chambers designed to accommodate a single patient during treatment sessions. They find applications in wound healing, decompression sickness, infection treatment, gas embolism, and other medical conditions and are utilized by hospitals, home care facilities, and other healthcare settings.
The hyperbaric oxygen therapy (HBOT) device market consists of sales of portable hyperbaric chambers, hyperbaric oxygen concentrators, and hyperbaric oxygen therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hyperbaric Oxygen Therapy Devices Market Characteristics
3. Hyperbaric Oxygen Therapy Devices Market Supply Chain Analysis
4. Global Hyperbaric Oxygen Therapy Devices Market Trends and Strategies
5. Hyperbaric Oxygen Therapy Devices Market Analysis of End Use Industries
7. Global Hyperbaric Oxygen Therapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hyperbaric Oxygen Therapy Devices Total Addressable Market (TAM) Analysis for the Market
9. Hyperbaric Oxygen Therapy Devices Market Segmentation
10. Hyperbaric Oxygen Therapy Devices Market Regional and Country Analysis
11. Asia-Pacific Hyperbaric Oxygen Therapy Devices Market
12. China Hyperbaric Oxygen Therapy Devices Market
13. India Hyperbaric Oxygen Therapy Devices Market
14. Japan Hyperbaric Oxygen Therapy Devices Market
15. Australia Hyperbaric Oxygen Therapy Devices Market
16. Indonesia Hyperbaric Oxygen Therapy Devices Market
17. South Korea Hyperbaric Oxygen Therapy Devices Market
18. Taiwan Hyperbaric Oxygen Therapy Devices Market
19. South East Asia Hyperbaric Oxygen Therapy Devices Market
20. Western Europe Hyperbaric Oxygen Therapy Devices Market
21. UK Hyperbaric Oxygen Therapy Devices Market
22. Germany Hyperbaric Oxygen Therapy Devices Market
23. France Hyperbaric Oxygen Therapy Devices Market
24. Italy Hyperbaric Oxygen Therapy Devices Market
25. Spain Hyperbaric Oxygen Therapy Devices Market
26. Eastern Europe Hyperbaric Oxygen Therapy Devices Market
27. Russia Hyperbaric Oxygen Therapy Devices Market
28. North America Hyperbaric Oxygen Therapy Devices Market
29. USA Hyperbaric Oxygen Therapy Devices Market
30. Canada Hyperbaric Oxygen Therapy Devices Market
31. South America Hyperbaric Oxygen Therapy Devices Market
32. Brazil Hyperbaric Oxygen Therapy Devices Market
33. Middle East Hyperbaric Oxygen Therapy Devices Market
34. Africa Hyperbaric Oxygen Therapy Devices Market
36. Hyperbaric Oxygen Therapy Devices Market Competitive Landscape and Company Profiles
37. Hyperbaric Oxygen Therapy Devices Market Other Major and Innovative Companies
40. Hyperbaric Oxygen Therapy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hyperbaric Oxygen Therapy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hyperbaric oxygen therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hyperbaric oxygen therapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hyperbaric oxygen therapy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Monoplace Hyperbaric Oxygen Therapy Devices; Multiplace Hyperbaric Oxygen Therapy Devices2) By Application: Wound Healing; Decompression Sickness; Infection Treatment; Gas Embolism; Other Applications
3) By End User: Hospitals; Home Care; Other End Users
Subsegments:
1) By Monoplace Hyperbaric Oxygen Therapy Devices: Single-Person Chamber Systems; Fixed Monoplace Hbot Chambers; High-Pressure Monoplace Oxygen Chambers2) By Multiplace Hyperbaric Oxygen Therapy Devices: Two-Person Multiplace Chambers; Multi-Person Chamber Systems (4-10 Persons); Large Multiplace Hyperbaric Chambers; High-Capacity Multiplace Hbot Devices; Advanced Multiplace Oxygen Chambers
Companies Mentioned: Environmental Tectonics Corporation; Sechrist Industries; Perry Baromedical; HAUX Life Support; Fink Engineering; OxyHelp Industry; Environmental Control Systems; BioBarica; OxyHeal Health Group; Hyperbaric Modular Systems; Baroks Hyperbaric; Oxyvein Hyperbaric Chambers; Hpotech Medical Solutions; Shanghai Baobang Medical Equipment; Jiangsu Haila Resuscitation Equipment; Hyperbaric SAC; Pan America Hyperbarics Manufacturing; Oxymed Hyperbaric Chambers; Vitaeris Hyperbaric Systems; SOS Group Hyperbaric Engineering; ETC Hyperbaric Solutions; OxyAir Hyperbaric Technology
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hyperbaric Oxygen Therapy Devices market report include:- Environmental Tectonics Corporation
- Sechrist Industries
- Perry Baromedical
- HAUX Life Support
- Fink Engineering
- OxyHelp Industry
- Environmental Control Systems
- BioBarica
- OxyHeal Health Group
- Hyperbaric Modular Systems
- Baroks Hyperbaric
- Oxyvein Hyperbaric Chambers
- Hpotech Medical Solutions
- Shanghai Baobang Medical Equipment
- Jiangsu Haila Resuscitation Equipment
- Hyperbaric SAC
- Pan America Hyperbarics Manufacturing
- Oxymed Hyperbaric Chambers
- Vitaeris Hyperbaric Systems
- SOS Group Hyperbaric Engineering
- ETC Hyperbaric Solutions
- OxyAir Hyperbaric Technology
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.01 Billion |
| Forecasted Market Value ( USD | $ 6.85 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
